Drug Type Small molecule drug |
Synonyms Delucemine, Delucemine hydrochloride (USAN), NPS 1506 + [1] |
Target |
Mechanism NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18ClF2N |
InChIKeyMGNMVYXIKDNAKK-UHFFFAOYSA-N |
CAS Registry186495-99-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03679 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Craniocerebral Trauma | Phase 1 | US | - | |
Depressive Disorder, Major | Phase 1 | US | - | |
Depressive Disorder, Major | Phase 1 | - | - | |
Stroke | Phase 1 | US | - |